nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—CYP3A4—Temozolomide—brain cancer	0.0649	0.278	CbGbCtD
Midazolam—CYP3A4—Lomustine—brain cancer	0.0552	0.236	CbGbCtD
Midazolam—CYP2E1—Etoposide—brain cancer	0.044	0.188	CbGbCtD
Midazolam—CYP3A5—Etoposide—brain cancer	0.0342	0.146	CbGbCtD
Midazolam—ABCB1—Etoposide—brain cancer	0.0223	0.0952	CbGbCtD
Midazolam—CYP3A4—Etoposide—brain cancer	0.0133	0.057	CbGbCtD
Midazolam—Slurred speech—Procarbazine—brain cancer	0.0093	0.0262	CcSEcCtD
Midazolam—Skin necrosis—Hydroxyurea—brain cancer	0.00921	0.026	CcSEcCtD
Midazolam—GABRG1—ganglion—brain cancer	0.00856	0.0292	CbGeAlD
Midazolam—Skin necrosis—Carmustine—brain cancer	0.00745	0.021	CcSEcCtD
Midazolam—Dysarthria—Lomustine—brain cancer	0.00693	0.0195	CcSEcCtD
Midazolam—GABRA6—hindbrain—brain cancer	0.00646	0.0221	CbGeAlD
Midazolam—Phlebitis—Carboplatin—brain cancer	0.00631	0.0178	CcSEcCtD
Midazolam—Thrombosis—Procarbazine—brain cancer	0.00588	0.0166	CcSEcCtD
Midazolam—Nystagmus—Procarbazine—brain cancer	0.00582	0.0164	CcSEcCtD
Midazolam—Skin necrosis—Etoposide—brain cancer	0.00576	0.0162	CcSEcCtD
Midazolam—GABRA2—ganglion—brain cancer	0.00573	0.0196	CbGeAlD
Midazolam—CYP4B1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00545	0.049	CbGpPWpGaD
Midazolam—SLC22A1—ganglion—brain cancer	0.00541	0.0185	CbGeAlD
Midazolam—Disorientation—Lomustine—brain cancer	0.00532	0.015	CcSEcCtD
Midazolam—Dysphonia—Procarbazine—brain cancer	0.00506	0.0143	CcSEcCtD
Midazolam—Visual disturbance—Lomustine—brain cancer	0.00502	0.0142	CcSEcCtD
Midazolam—UGT1A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00502	0.045	CbGpPWpGaD
Midazolam—Lethargy—Lomustine—brain cancer	0.00485	0.0137	CcSEcCtD
Midazolam—Digestion impaired—Hydroxyurea—brain cancer	0.00482	0.0136	CcSEcCtD
Midazolam—Osteoarthritis—Lomustine—brain cancer	0.00476	0.0134	CcSEcCtD
Midazolam—GABRB2—hindbrain—brain cancer	0.00475	0.0162	CbGeAlD
Midazolam—GABRQ—telencephalon—brain cancer	0.00473	0.0162	CbGeAlD
Midazolam—Induration—Etoposide—brain cancer	0.0045	0.0127	CcSEcCtD
Midazolam—Ataxia—Lomustine—brain cancer	0.00447	0.0126	CcSEcCtD
Midazolam—Dysarthria—Procarbazine—brain cancer	0.0044	0.0124	CcSEcCtD
Midazolam—GABRA2—hindbrain—brain cancer	0.00434	0.0148	CbGeAlD
Midazolam—GABRA1—hindbrain—brain cancer	0.0042	0.0143	CbGeAlD
Midazolam—CYP4B1—pituitary gland—brain cancer	0.00415	0.0142	CbGeAlD
Midazolam—Nightmare—Procarbazine—brain cancer	0.00402	0.0113	CcSEcCtD
Midazolam—CYP4B1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00401	0.036	CbGpPWpGaD
Midazolam—Digestion impaired—Temozolomide—brain cancer	0.00376	0.0106	CcSEcCtD
Midazolam—GABRA6—brainstem—brain cancer	0.0037	0.0126	CbGeAlD
Midazolam—Tenderness—Hydroxyurea—brain cancer	0.00369	0.0104	CcSEcCtD
Midazolam—Thrombosis—Carmustine—brain cancer	0.00368	0.0104	CcSEcCtD
Midazolam—UGT1A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00358	0.0322	CbGpPWpGaD
Midazolam—CYP4B1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00346	0.0311	CbGpPWpGaD
Midazolam—GABRD—telencephalon—brain cancer	0.00343	0.0117	CbGeAlD
Midazolam—CYP4B1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00342	0.0307	CbGpPWpGaD
Midazolam—Disorientation—Procarbazine—brain cancer	0.00338	0.00952	CcSEcCtD
Midazolam—GABRG3—pituitary gland—brain cancer	0.00337	0.0115	CbGeAlD
Midazolam—GABRG1—telencephalon—brain cancer	0.0033	0.0113	CbGeAlD
Midazolam—GABRA6—telencephalon—brain cancer	0.00328	0.0112	CbGeAlD
Midazolam—UGT1A4—endocrine gland—brain cancer	0.00326	0.0111	CbGeAlD
Midazolam—GABRB1—telencephalon—brain cancer	0.0032	0.0109	CbGeAlD
Midazolam—Injection site pain—Carmustine—brain cancer	0.00319	0.00899	CcSEcCtD
Midazolam—GABRA5—telencephalon—brain cancer	0.00319	0.0109	CbGeAlD
Midazolam—CYP4B1—head—brain cancer	0.00317	0.0108	CbGeAlD
Midazolam—Visual impairment—Lomustine—brain cancer	0.00317	0.00894	CcSEcCtD
Midazolam—Lethargy—Procarbazine—brain cancer	0.00308	0.00869	CcSEcCtD
Midazolam—Skin exfoliation—Hydroxyurea—brain cancer	0.00307	0.00867	CcSEcCtD
Midazolam—Diplopia—Procarbazine—brain cancer	0.00302	0.00852	CcSEcCtD
Midazolam—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00301	0.027	CbGpPWpGaD
Midazolam—GABRR3—head—brain cancer	0.00295	0.0101	CbGeAlD
Midazolam—GABRQ—head—brain cancer	0.00295	0.0101	CbGeAlD
Midazolam—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.00294	0.0264	CbGpPWpGaD
Midazolam—GABRA4—telencephalon—brain cancer	0.00289	0.00987	CbGeAlD
Midazolam—Ataxia—Procarbazine—brain cancer	0.00284	0.00801	CcSEcCtD
Midazolam—CYP4B1—cerebellum—brain cancer	0.00283	0.00967	CbGeAlD
Midazolam—CYP4B1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00281	0.0252	CbGpPWpGaD
Midazolam—GABRB2—brainstem—brain cancer	0.00272	0.0093	CbGeAlD
Midazolam—GABRD—medulla oblongata—brain cancer	0.0027	0.00921	CbGeAlD
Midazolam—Laryngospasm—Etoposide—brain cancer	0.0027	0.0076	CcSEcCtD
Midazolam—GABRQ—central nervous system—brain cancer	0.00269	0.00918	CbGeAlD
Midazolam—Disorientation—Hydroxyurea—brain cancer	0.00261	0.00737	CcSEcCtD
Midazolam—GABRB1—pituitary gland—brain cancer	0.00261	0.00891	CbGeAlD
Midazolam—GABRG1—medulla oblongata—brain cancer	0.0026	0.00886	CbGeAlD
Midazolam—GABRG3—head—brain cancer	0.00258	0.00881	CbGeAlD
Midazolam—Respiratory failure—Temozolomide—brain cancer	0.00256	0.00722	CcSEcCtD
Midazolam—GABRR2—head—brain cancer	0.00255	0.00872	CbGeAlD
Midazolam—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.00252	0.0226	CbGpPWpGaD
Midazolam—GABRB1—medulla oblongata—brain cancer	0.00252	0.0086	CbGeAlD
Midazolam—Depressed level of consciousness—Carmustine—brain cancer	0.00251	0.00709	CcSEcCtD
Midazolam—GABRA2—brainstem—brain cancer	0.00249	0.0085	CbGeAlD
Midazolam—Skin exfoliation—Carmustine—brain cancer	0.00248	0.00701	CcSEcCtD
Midazolam—GABRD—midbrain—brain cancer	0.00246	0.00842	CbGeAlD
Midazolam—GABRR1—head—brain cancer	0.00246	0.0084	CbGeAlD
Midazolam—Depressed level of consciousness—Temozolomide—brain cancer	0.00243	0.00685	CcSEcCtD
Midazolam—GABRG2—telencephalon—brain cancer	0.00242	0.00826	CbGeAlD
Midazolam—GABRB2—telencephalon—brain cancer	0.00242	0.00826	CbGeAlD
Midazolam—GABRA1—brainstem—brain cancer	0.00241	0.00822	CbGeAlD
Midazolam—Skin exfoliation—Temozolomide—brain cancer	0.0024	0.00677	CcSEcCtD
Midazolam—Apnoea—Etoposide—brain cancer	0.00237	0.0067	CcSEcCtD
Midazolam—GABRG1—midbrain—brain cancer	0.00237	0.0081	CbGeAlD
Midazolam—GABRG3—central nervous system—brain cancer	0.00236	0.00804	CbGeAlD
Midazolam—GABRA4—pituitary gland—brain cancer	0.00235	0.00804	CbGeAlD
Midazolam—GABRP—pituitary gland—brain cancer	0.00234	0.00798	CbGeAlD
Midazolam—Drowsiness—Procarbazine—brain cancer	0.00233	0.00656	CcSEcCtD
Midazolam—GABRG1—spinal cord—brain cancer	0.00231	0.0079	CbGeAlD
Midazolam—GABRB1—midbrain—brain cancer	0.0023	0.00786	CbGeAlD
Midazolam—CYP4B1—brain—brain cancer	0.0023	0.00785	CbGeAlD
Midazolam—Pain—Carboplatin—brain cancer	0.00229	0.00645	CcSEcCtD
Midazolam—Neuropathy peripheral—Procarbazine—brain cancer	0.00228	0.00643	CcSEcCtD
Midazolam—GABRR2—cerebellum—brain cancer	0.00228	0.00778	CbGeAlD
Midazolam—CYP3A7—endocrine gland—brain cancer	0.00227	0.00775	CbGeAlD
Midazolam—GABRR1—central nervous system—brain cancer	0.00224	0.00767	CbGeAlD
Midazolam—GABRB1—spinal cord—brain cancer	0.00224	0.00766	CbGeAlD
Midazolam—GABRA2—telencephalon—brain cancer	0.00221	0.00754	CbGeAlD
Midazolam—Phlebitis—Carmustine—brain cancer	0.00219	0.00619	CcSEcCtD
Midazolam—Thrombophlebitis—Carmustine—brain cancer	0.00218	0.00616	CcSEcCtD
Midazolam—Swelling—Carmustine—brain cancer	0.00214	0.00604	CcSEcCtD
Midazolam—GABRD—head—brain cancer	0.00214	0.0073	CbGeAlD
Midazolam—GABRQ—brain—brain cancer	0.00214	0.00729	CbGeAlD
Midazolam—GABRA1—telencephalon—brain cancer	0.00214	0.00729	CbGeAlD
Midazolam—Thrombophlebitis—Temozolomide—brain cancer	0.00211	0.00595	CcSEcCtD
Midazolam—SLC22A1—telencephalon—brain cancer	0.00209	0.00712	CbGeAlD
Midazolam—Hallucination—Procarbazine—brain cancer	0.00208	0.00586	CcSEcCtD
Midazolam—GABRG1—head—brain cancer	0.00206	0.00703	CbGeAlD
Midazolam—Injury—Carmustine—brain cancer	0.00206	0.0058	CcSEcCtD
Midazolam—GABRA6—head—brain cancer	0.00205	0.00698	CbGeAlD
Midazolam—GABRB1—head—brain cancer	0.00199	0.00681	CbGeAlD
Midazolam—GABRA5—head—brain cancer	0.00198	0.00678	CbGeAlD
Midazolam—GABRG2—pituitary gland—brain cancer	0.00197	0.00672	CbGeAlD
Midazolam—GABRD—central nervous system—brain cancer	0.00195	0.00666	CbGeAlD
Midazolam—Skin exfoliation—Etoposide—brain cancer	0.00192	0.00542	CcSEcCtD
Midazolam—GABRD—cerebellum—brain cancer	0.00191	0.00651	CbGeAlD
Midazolam—GABRB2—medulla oblongata—brain cancer	0.0019	0.00649	CbGeAlD
Midazolam—GABRG2—medulla oblongata—brain cancer	0.0019	0.00649	CbGeAlD
Midazolam—Diplopia—Carmustine—brain cancer	0.00189	0.00533	CcSEcCtD
Midazolam—GABRG1—central nervous system—brain cancer	0.00188	0.00641	CbGeAlD
Midazolam—Chills—Procarbazine—brain cancer	0.00187	0.00529	CcSEcCtD
Midazolam—GABRA3—endocrine gland—brain cancer	0.00187	0.00639	CbGeAlD
Midazolam—GABRG3—brain—brain cancer	0.00187	0.00639	CbGeAlD
Midazolam—GABRA6—central nervous system—brain cancer	0.00187	0.00638	CbGeAlD
Midazolam—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.00186	0.0167	CbGpPWpGaD
Midazolam—GABRB3—telencephalon—brain cancer	0.00186	0.00634	CbGeAlD
Midazolam—GABRA3—head—brain cancer	0.00185	0.00631	CbGeAlD
Midazolam—GABRG1—cerebellum—brain cancer	0.00184	0.00627	CbGeAlD
Midazolam—Diplopia—Temozolomide—brain cancer	0.00183	0.00515	CcSEcCtD
Midazolam—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.00183	0.0164	CbGpPWpGaD
Midazolam—GABRA6—cerebellum—brain cancer	0.00182	0.00623	CbGeAlD
Midazolam—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.00182	0.0164	CbGpPWpGaD
Midazolam—GABRB1—central nervous system—brain cancer	0.00182	0.00622	CbGeAlD
Midazolam—GABRA5—central nervous system—brain cancer	0.00181	0.00618	CbGeAlD
Midazolam—Drowsiness—Hydroxyurea—brain cancer	0.0018	0.00508	CcSEcCtD
Midazolam—GABRA4—head—brain cancer	0.0018	0.00615	CbGeAlD
Midazolam—Affect lability—Temozolomide—brain cancer	0.0018	0.00507	CcSEcCtD
Midazolam—GABRP—head—brain cancer	0.00179	0.0061	CbGeAlD
Midazolam—Tension—Procarbazine—brain cancer	0.00178	0.00503	CcSEcCtD
Midazolam—GABRE—pituitary gland—brain cancer	0.00178	0.00609	CbGeAlD
Midazolam—GABRR1—brain—brain cancer	0.00178	0.00609	CbGeAlD
Midazolam—GABRB1—cerebellum—brain cancer	0.00178	0.00608	CbGeAlD
Midazolam—Ataxia—Carmustine—brain cancer	0.00178	0.00501	CcSEcCtD
Midazolam—Nervousness—Procarbazine—brain cancer	0.00177	0.00498	CcSEcCtD
Midazolam—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00177	0.00498	CcSEcCtD
Midazolam—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00176	0.0158	CbGpPWpGaD
Midazolam—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.00175	0.0157	CbGpPWpGaD
Midazolam—GABRG2—midbrain—brain cancer	0.00174	0.00593	CbGeAlD
Midazolam—GABRB2—midbrain—brain cancer	0.00174	0.00593	CbGeAlD
Midazolam—Mood swings—Temozolomide—brain cancer	0.00173	0.00488	CcSEcCtD
Midazolam—Ataxia—Temozolomide—brain cancer	0.00172	0.00484	CcSEcCtD
Midazolam—Tremor—Procarbazine—brain cancer	0.0017	0.00481	CcSEcCtD
Midazolam—Phlebitis—Etoposide—brain cancer	0.0017	0.00478	CcSEcCtD
Midazolam—GABRB2—spinal cord—brain cancer	0.00169	0.00579	CbGeAlD
Midazolam—GABRG2—spinal cord—brain cancer	0.00169	0.00579	CbGeAlD
Midazolam—GABRA3—central nervous system—brain cancer	0.00169	0.00576	CbGeAlD
Midazolam—GABRA1—medulla oblongata—brain cancer	0.00168	0.00573	CbGeAlD
Midazolam—Muscular weakness—Carmustine—brain cancer	0.00167	0.0047	CcSEcCtD
Midazolam—Swelling—Etoposide—brain cancer	0.00166	0.00467	CcSEcCtD
Midazolam—GABRA4—central nervous system—brain cancer	0.00164	0.00561	CbGeAlD
Midazolam—Syncope—Procarbazine—brain cancer	0.00163	0.0046	CcSEcCtD
Midazolam—Muscular weakness—Temozolomide—brain cancer	0.00161	0.00454	CcSEcCtD
Midazolam—Hallucination—Hydroxyurea—brain cancer	0.00161	0.00454	CcSEcCtD
Midazolam—GABRA4—cerebellum—brain cancer	0.00161	0.00548	CbGeAlD
Midazolam—GABRQ—Orphan transporters—S100A10—brain cancer	0.0016	0.0143	CbGpPWpGaD
Midazolam—Cough—Procarbazine—brain cancer	0.00159	0.00448	CcSEcCtD
Midazolam—GABRB3—gonad—brain cancer	0.00155	0.00529	CbGeAlD
Midazolam—GABRD—brain—brain cancer	0.00155	0.00529	CbGeAlD
Midazolam—Anxiety—Procarbazine—brain cancer	0.00154	0.00435	CcSEcCtD
Midazolam—GABRA1—midbrain—brain cancer	0.00153	0.00524	CbGeAlD
Midazolam—Dry mouth—Procarbazine—brain cancer	0.00151	0.00427	CcSEcCtD
Midazolam—GABRB3—pituitary gland—brain cancer	0.00151	0.00516	CbGeAlD
Midazolam—Anaphylactoid reaction—Etoposide—brain cancer	0.00151	0.00426	CcSEcCtD
Midazolam—GABRG2—head—brain cancer	0.00151	0.00514	CbGeAlD
Midazolam—GABRB2—head—brain cancer	0.00151	0.00514	CbGeAlD
Midazolam—Cardiac failure—Etoposide—brain cancer	0.0015	0.00422	CcSEcCtD
Midazolam—Confusional state—Procarbazine—brain cancer	0.0015	0.00422	CcSEcCtD
Midazolam—GABRA1—spinal cord—brain cancer	0.0015	0.00511	CbGeAlD
Midazolam—Alprazolam—CYP2C9—brain cancer	0.0015	0.204	CrCbGaD
Midazolam—CYP4B1—Biological oxidations—CYP2C9—brain cancer	0.00149	0.0134	CbGpPWpGaD
Midazolam—GABRG1—brain—brain cancer	0.00149	0.00509	CbGeAlD
Midazolam—Vomiting—Lomustine—brain cancer	0.00149	0.00419	CcSEcCtD
Midazolam—GABRA6—brain—brain cancer	0.00148	0.00506	CbGeAlD
Midazolam—CYP4B1—Metapathway biotransformation—CYP2C9—brain cancer	0.00147	0.0132	CbGpPWpGaD
Midazolam—Shock—Procarbazine—brain cancer	0.00146	0.00412	CcSEcCtD
Midazolam—GABRB3—medulla oblongata—brain cancer	0.00146	0.00498	CbGeAlD
Midazolam—Depression—Carmustine—brain cancer	0.00145	0.00409	CcSEcCtD
Midazolam—Chills—Hydroxyurea—brain cancer	0.00145	0.00409	CcSEcCtD
Midazolam—Quazepam—CYP2C9—brain cancer	0.00145	0.198	CrCbGaD
Midazolam—Tachycardia—Procarbazine—brain cancer	0.00145	0.00409	CcSEcCtD
Midazolam—GABRB1—brain—brain cancer	0.00145	0.00494	CbGeAlD
Midazolam—GABRA5—brain—brain cancer	0.00144	0.00491	CbGeAlD
Midazolam—Neuropathy peripheral—Carmustine—brain cancer	0.00143	0.00403	CcSEcCtD
Midazolam—Erythema—Hydroxyurea—brain cancer	0.00141	0.00397	CcSEcCtD
Midazolam—Depression—Temozolomide—brain cancer	0.0014	0.00396	CcSEcCtD
Midazolam—Cardiac arrest—Etoposide—brain cancer	0.00139	0.00392	CcSEcCtD
Midazolam—Nausea—Lomustine—brain cancer	0.00139	0.00392	CcSEcCtD
Midazolam—ABCB1—blood vessel—brain cancer	0.00139	0.00474	CbGeAlD
Midazolam—Hypotension—Procarbazine—brain cancer	0.00139	0.00391	CcSEcCtD
Midazolam—Neuropathy peripheral—Temozolomide—brain cancer	0.00138	0.00389	CcSEcCtD
Midazolam—GABRA2—head—brain cancer	0.00138	0.0047	CbGeAlD
Midazolam—GABRB2—central nervous system—brain cancer	0.00137	0.00469	CbGeAlD
Midazolam—GABRG2—central nervous system—brain cancer	0.00137	0.00469	CbGeAlD
Midazolam—Flunitrazepam—CYP2C9—brain cancer	0.00137	0.187	CrCbGaD
Midazolam—GABRE—head—brain cancer	0.00136	0.00466	CbGeAlD
Midazolam—GABRG2—cerebellum—brain cancer	0.00134	0.00459	CbGeAlD
Midazolam—GABRB2—cerebellum—brain cancer	0.00134	0.00459	CbGeAlD
Midazolam—GABRA3—brain—brain cancer	0.00134	0.00457	CbGeAlD
Midazolam—GABRB3—midbrain—brain cancer	0.00133	0.00455	CbGeAlD
Midazolam—Paraesthesia—Procarbazine—brain cancer	0.00133	0.00376	CcSEcCtD
Midazolam—GABRA1—head—brain cancer	0.00133	0.00454	CbGeAlD
Midazolam—Somnolence—Procarbazine—brain cancer	0.00132	0.00372	CcSEcCtD
Midazolam—SLC22A1—endocrine gland—brain cancer	0.00132	0.00449	CbGeAlD
Midazolam—GABRG3—Orphan transporters—S100A10—brain cancer	0.00131	0.0118	CbGpPWpGaD
Midazolam—GABRA4—brain—brain cancer	0.0013	0.00445	CbGeAlD
Midazolam—GABRB3—spinal cord—brain cancer	0.0013	0.00444	CbGeAlD
Midazolam—Hallucination—Carmustine—brain cancer	0.0013	0.00367	CcSEcCtD
Midazolam—SLC22A1—head—brain cancer	0.0013	0.00444	CbGeAlD
Midazolam—GABRB1—Orphan transporters—S100A10—brain cancer	0.00129	0.0116	CbGpPWpGaD
Midazolam—Connective tissue disorder—Carmustine—brain cancer	0.00128	0.00362	CcSEcCtD
Midazolam—Fatigue—Procarbazine—brain cancer	0.00128	0.00361	CcSEcCtD
Midazolam—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00128	0.0115	CbGpPWpGaD
Midazolam—Constipation—Procarbazine—brain cancer	0.00127	0.00358	CcSEcCtD
Midazolam—Pain—Procarbazine—brain cancer	0.00127	0.00358	CcSEcCtD
Midazolam—Visual impairment—Carmustine—brain cancer	0.00126	0.00355	CcSEcCtD
Midazolam—Hallucination—Temozolomide—brain cancer	0.00126	0.00354	CcSEcCtD
Midazolam—GABRA2—central nervous system—brain cancer	0.00126	0.00429	CbGeAlD
Midazolam—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00125	0.0112	CbGpPWpGaD
Midazolam—GABRE—central nervous system—brain cancer	0.00125	0.00425	CbGeAlD
Midazolam—Bronchospasm—Etoposide—brain cancer	0.00124	0.0035	CcSEcCtD
Midazolam—Connective tissue disorder—Temozolomide—brain cancer	0.00124	0.0035	CcSEcCtD
Midazolam—GABRA2—cerebellum—brain cancer	0.00123	0.00419	CbGeAlD
Midazolam—GABRA6—Orphan transporters—S100A10—brain cancer	0.00122	0.011	CbGpPWpGaD
Midazolam—Feeling abnormal—Procarbazine—brain cancer	0.00122	0.00345	CcSEcCtD
Midazolam—Eye disorder—Carmustine—brain cancer	0.00122	0.00345	CcSEcCtD
Midazolam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00122	0.0109	CbGpPWpGaD
Midazolam—Visual impairment—Temozolomide—brain cancer	0.00122	0.00343	CcSEcCtD
Midazolam—GABRA1—central nervous system—brain cancer	0.00121	0.00414	CbGeAlD
Midazolam—GABRA4—Orphan transporters—S100A10—brain cancer	0.00121	0.0109	CbGpPWpGaD
Midazolam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00119	0.0107	CbGpPWpGaD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00119	0.00336	CcSEcCtD
Midazolam—GABRA1—cerebellum—brain cancer	0.00119	0.00405	CbGeAlD
Midazolam—SLC22A1—central nervous system—brain cancer	0.00119	0.00405	CbGeAlD
Midazolam—CYP2E1—telencephalon—brain cancer	0.00118	0.00403	CbGeAlD
Midazolam—Eye disorder—Temozolomide—brain cancer	0.00118	0.00333	CcSEcCtD
Midazolam—Urticaria—Procarbazine—brain cancer	0.00118	0.00333	CcSEcCtD
Midazolam—Cardiac disorder—Temozolomide—brain cancer	0.00117	0.00331	CcSEcCtD
Midazolam—GABRB3—endocrine gland—brain cancer	0.00117	0.004	CbGeAlD
Midazolam—GABRB3—head—brain cancer	0.00116	0.00395	CbGeAlD
Midazolam—Mental disorder—Carmustine—brain cancer	0.00115	0.00323	CcSEcCtD
Midazolam—Immune system disorder—Temozolomide—brain cancer	0.00114	0.00322	CcSEcCtD
Midazolam—Mediastinal disorder—Temozolomide—brain cancer	0.00114	0.00321	CcSEcCtD
Midazolam—Erythema—Carmustine—brain cancer	0.00114	0.00321	CcSEcCtD
Midazolam—Chills—Temozolomide—brain cancer	0.00113	0.0032	CcSEcCtD
Midazolam—Nervous system disorder—Hydroxyurea—brain cancer	0.00113	0.00318	CcSEcCtD
Midazolam—Skin disorder—Hydroxyurea—brain cancer	0.00112	0.00315	CcSEcCtD
Midazolam—Mental disorder—Temozolomide—brain cancer	0.00111	0.00312	CcSEcCtD
Midazolam—GABRB2—Orphan transporters—S100A10—brain cancer	0.00111	0.00993	CbGpPWpGaD
Midazolam—Neuropathy peripheral—Etoposide—brain cancer	0.0011	0.00311	CcSEcCtD
Midazolam—Erythema—Temozolomide—brain cancer	0.0011	0.0031	CcSEcCtD
Midazolam—Triazolam—CYP2C9—brain cancer	0.0011	0.15	CrCbGaD
Midazolam—Hypersensitivity—Procarbazine—brain cancer	0.00109	0.00308	CcSEcCtD
Midazolam—GABRG2—brain—brain cancer	0.00109	0.00373	CbGeAlD
Midazolam—GABRB2—brain—brain cancer	0.00109	0.00373	CbGeAlD
Midazolam—GABRA5—Orphan transporters—S100A10—brain cancer	0.00107	0.00965	CbGpPWpGaD
Midazolam—Vision blurred—Carmustine—brain cancer	0.00107	0.00302	CcSEcCtD
Midazolam—Tremor—Carmustine—brain cancer	0.00107	0.00301	CcSEcCtD
Midazolam—Asthenia—Procarbazine—brain cancer	0.00106	0.003	CcSEcCtD
Midazolam—GABRB3—central nervous system—brain cancer	0.00106	0.0036	CbGeAlD
Midazolam—GABRA3—Orphan transporters—S100A10—brain cancer	0.00106	0.00948	CbGpPWpGaD
Midazolam—Temazepam—CYP2C9—brain cancer	0.00105	0.143	CrCbGaD
Midazolam—CYP2B6—gonad—brain cancer	0.00105	0.00359	CbGeAlD
Midazolam—Pruritus—Procarbazine—brain cancer	0.00105	0.00296	CcSEcCtD
Midazolam—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00105	0.00939	CbGpPWpGaD
Midazolam—Agitation—Carmustine—brain cancer	0.00105	0.00295	CcSEcCtD
Midazolam—GABRA2—Orphan transporters—S100A10—brain cancer	0.00104	0.00931	CbGpPWpGaD
Midazolam—Vision blurred—Temozolomide—brain cancer	0.00104	0.00292	CcSEcCtD
Midazolam—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00103	0.00927	CbGpPWpGaD
Midazolam—GABRB3—cerebellum—brain cancer	0.00103	0.00352	CbGeAlD
Midazolam—GABRB3—Orphan transporters—S100A10—brain cancer	0.00103	0.00925	CbGpPWpGaD
Midazolam—Tremor—Temozolomide—brain cancer	0.00103	0.00291	CcSEcCtD
Midazolam—Dyspnoea—Hydroxyurea—brain cancer	0.00102	0.00289	CcSEcCtD
Midazolam—Somnolence—Hydroxyurea—brain cancer	0.00102	0.00288	CcSEcCtD
Midazolam—GABRG2—Orphan transporters—S100A10—brain cancer	0.00101	0.00908	CbGpPWpGaD
Midazolam—Dyspepsia—Hydroxyurea—brain cancer	0.00101	0.00285	CcSEcCtD
Midazolam—Agitation—Temozolomide—brain cancer	0.00101	0.00285	CcSEcCtD
Midazolam—GABRA2—brain—brain cancer	0.000997	0.0034	CbGeAlD
Midazolam—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000992	0.0028	CcSEcCtD
Midazolam—Fatigue—Hydroxyurea—brain cancer	0.00099	0.00279	CcSEcCtD
Midazolam—GABRE—brain—brain cancer	0.000989	0.00338	CbGeAlD
Midazolam—Vertigo—Temozolomide—brain cancer	0.000988	0.00279	CcSEcCtD
Midazolam—Constipation—Hydroxyurea—brain cancer	0.000982	0.00277	CcSEcCtD
Midazolam—Pain—Hydroxyurea—brain cancer	0.000982	0.00277	CcSEcCtD
Midazolam—Dizziness—Procarbazine—brain cancer	0.000981	0.00277	CcSEcCtD
Midazolam—Anxiety—Carmustine—brain cancer	0.000965	0.00272	CcSEcCtD
Midazolam—GABRA1—brain—brain cancer	0.000963	0.00329	CbGeAlD
Midazolam—UGT1A4—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000962	0.00864	CbGpPWpGaD
Midazolam—Cough—Temozolomide—brain cancer	0.000959	0.00271	CcSEcCtD
Midazolam—Feeling abnormal—Hydroxyurea—brain cancer	0.000947	0.00267	CcSEcCtD
Midazolam—Eye disorder—Etoposide—brain cancer	0.000945	0.00266	CcSEcCtD
Midazolam—Vomiting—Procarbazine—brain cancer	0.000944	0.00266	CcSEcCtD
Midazolam—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000944	0.00847	CbGpPWpGaD
Midazolam—SLC22A1—brain—brain cancer	0.000941	0.00321	CbGeAlD
Midazolam—Cardiac disorder—Etoposide—brain cancer	0.000938	0.00265	CcSEcCtD
Midazolam—Confusional state—Carmustine—brain cancer	0.000936	0.00264	CcSEcCtD
Midazolam—Rash—Procarbazine—brain cancer	0.000936	0.00264	CcSEcCtD
Midazolam—Dermatitis—Procarbazine—brain cancer	0.000935	0.00264	CcSEcCtD
Midazolam—Anxiety—Temozolomide—brain cancer	0.000933	0.00263	CcSEcCtD
Midazolam—UGT1A4—Biological oxidations—CYP2C9—brain cancer	0.000933	0.00837	CbGpPWpGaD
Midazolam—Headache—Procarbazine—brain cancer	0.00093	0.00262	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00093	0.00262	CcSEcCtD
Midazolam—CYP2E1—medulla oblongata—brain cancer	0.000928	0.00317	CbGeAlD
Midazolam—UGT1A4—Metapathway biotransformation—CYP2C9—brain cancer	0.00092	0.00826	CbGpPWpGaD
Midazolam—Dry mouth—Temozolomide—brain cancer	0.000916	0.00258	CcSEcCtD
Midazolam—Immune system disorder—Etoposide—brain cancer	0.000913	0.00258	CcSEcCtD
Midazolam—Mediastinal disorder—Etoposide—brain cancer	0.000911	0.00257	CcSEcCtD
Midazolam—Chills—Etoposide—brain cancer	0.000907	0.00256	CcSEcCtD
Midazolam—Tachycardia—Carmustine—brain cancer	0.000906	0.00256	CcSEcCtD
Midazolam—Confusional state—Temozolomide—brain cancer	0.000905	0.00255	CcSEcCtD
Midazolam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000899	0.00807	CbGpPWpGaD
Midazolam—Anaphylactic shock—Temozolomide—brain cancer	0.000897	0.00253	CcSEcCtD
Midazolam—GABRA1—Orphan transporters—S100A10—brain cancer	0.000884	0.00794	CbGpPWpGaD
Midazolam—Nausea—Procarbazine—brain cancer	0.000882	0.00249	CcSEcCtD
Midazolam—Nervous system disorder—Temozolomide—brain cancer	0.00088	0.00248	CcSEcCtD
Midazolam—Diazepam—CYP2C9—brain cancer	0.000873	0.119	CrCbGaD
Midazolam—Skin disorder—Temozolomide—brain cancer	0.000872	0.00246	CcSEcCtD
Midazolam—Hypotension—Carmustine—brain cancer	0.000868	0.00245	CcSEcCtD
Midazolam—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000848	0.00762	CbGpPWpGaD
Midazolam—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000847	0.0076	CbGpPWpGaD
Midazolam—Hypersensitivity—Hydroxyurea—brain cancer	0.000846	0.00239	CcSEcCtD
Midazolam—GABRB3—brain—brain cancer	0.000838	0.00286	CbGeAlD
Midazolam—Paraesthesia—Carmustine—brain cancer	0.000834	0.00235	CcSEcCtD
Midazolam—Dyspnoea—Carmustine—brain cancer	0.000828	0.00234	CcSEcCtD
Midazolam—CYP2E1—spinal cord—brain cancer	0.000828	0.00283	CbGeAlD
Midazolam—Somnolence—Carmustine—brain cancer	0.000826	0.00233	CcSEcCtD
Midazolam—Asthenia—Hydroxyurea—brain cancer	0.000824	0.00232	CcSEcCtD
Midazolam—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000814	0.00731	CbGpPWpGaD
Midazolam—Paraesthesia—Temozolomide—brain cancer	0.000806	0.00227	CcSEcCtD
Midazolam—Gastrointestinal disorder—Carmustine—brain cancer	0.000802	0.00226	CcSEcCtD
Midazolam—Dyspnoea—Temozolomide—brain cancer	0.0008	0.00226	CcSEcCtD
Midazolam—CYP3A5—endocrine gland—brain cancer	0.000799	0.00273	CbGeAlD
Midazolam—Somnolence—Temozolomide—brain cancer	0.000798	0.00225	CcSEcCtD
Midazolam—Constipation—Carmustine—brain cancer	0.000794	0.00224	CcSEcCtD
Midazolam—Pain—Carmustine—brain cancer	0.000794	0.00224	CcSEcCtD
Midazolam—CYP2B6—endocrine gland—brain cancer	0.000794	0.00271	CbGeAlD
Midazolam—Vertigo—Etoposide—brain cancer	0.00079	0.00223	CcSEcCtD
Midazolam—Dyspepsia—Temozolomide—brain cancer	0.00079	0.00223	CcSEcCtD
Midazolam—CYP2B6—head—brain cancer	0.000784	0.00268	CbGeAlD
Midazolam—Gastrointestinal disorder—Temozolomide—brain cancer	0.000775	0.00219	CcSEcCtD
Midazolam—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000774	0.00695	CbGpPWpGaD
Midazolam—Fatigue—Temozolomide—brain cancer	0.000774	0.00218	CcSEcCtD
Midazolam—Cough—Etoposide—brain cancer	0.000768	0.00217	CcSEcCtD
Midazolam—Pain—Temozolomide—brain cancer	0.000767	0.00216	CcSEcCtD
Midazolam—Constipation—Temozolomide—brain cancer	0.000767	0.00216	CcSEcCtD
Midazolam—Feeling abnormal—Carmustine—brain cancer	0.000765	0.00216	CcSEcCtD
Midazolam—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000764	0.00686	CbGpPWpGaD
Midazolam—Dizziness—Hydroxyurea—brain cancer	0.00076	0.00214	CcSEcCtD
Midazolam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000758	0.0068	CbGpPWpGaD
Midazolam—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000756	0.00679	CbGpPWpGaD
Midazolam—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000748	0.00672	CbGpPWpGaD
Midazolam—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000746	0.0067	CbGpPWpGaD
Midazolam—CYP2E1—endocrine gland—brain cancer	0.000745	0.00254	CbGeAlD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000744	0.0021	CcSEcCtD
Midazolam—Feeling abnormal—Temozolomide—brain cancer	0.000739	0.00209	CcSEcCtD
Midazolam—GABRB3—BDNF signaling pathway—NTRK3—brain cancer	0.000738	0.00663	CbGpPWpGaD
Midazolam—CYP2E1—head—brain cancer	0.000736	0.00251	CbGeAlD
Midazolam—Vomiting—Hydroxyurea—brain cancer	0.00073	0.00206	CcSEcCtD
Midazolam—Rash—Hydroxyurea—brain cancer	0.000724	0.00204	CcSEcCtD
Midazolam—Confusional state—Etoposide—brain cancer	0.000724	0.00204	CcSEcCtD
Midazolam—Dermatitis—Hydroxyurea—brain cancer	0.000724	0.00204	CcSEcCtD
Midazolam—Headache—Hydroxyurea—brain cancer	0.00072	0.00203	CcSEcCtD
Midazolam—Anaphylactic shock—Etoposide—brain cancer	0.000718	0.00203	CcSEcCtD
Midazolam—CYP2B6—central nervous system—brain cancer	0.000716	0.00244	CbGeAlD
Midazolam—Urticaria—Temozolomide—brain cancer	0.000713	0.00201	CcSEcCtD
Midazolam—Tachycardia—Etoposide—brain cancer	0.000701	0.00198	CcSEcCtD
Midazolam—Skin disorder—Etoposide—brain cancer	0.000697	0.00197	CcSEcCtD
Midazolam—Hypersensitivity—Carmustine—brain cancer	0.000684	0.00193	CcSEcCtD
Midazolam—Nausea—Hydroxyurea—brain cancer	0.000682	0.00192	CcSEcCtD
Midazolam—ABCB1—telencephalon—brain cancer	0.000673	0.0023	CbGeAlD
Midazolam—CYP2E1—central nervous system—brain cancer	0.000672	0.00229	CbGeAlD
Midazolam—Hypotension—Etoposide—brain cancer	0.000671	0.00189	CcSEcCtD
Midazolam—Asthenia—Carmustine—brain cancer	0.000666	0.00188	CcSEcCtD
Midazolam—Hypersensitivity—Temozolomide—brain cancer	0.000661	0.00186	CcSEcCtD
Midazolam—CYP2E1—cerebellum—brain cancer	0.000656	0.00224	CbGeAlD
Midazolam—Paraesthesia—Etoposide—brain cancer	0.000645	0.00182	CcSEcCtD
Midazolam—Asthenia—Temozolomide—brain cancer	0.000644	0.00182	CcSEcCtD
Midazolam—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000642	0.00577	CbGpPWpGaD
Midazolam—Dyspnoea—Etoposide—brain cancer	0.00064	0.00181	CcSEcCtD
Midazolam—Somnolence—Etoposide—brain cancer	0.000638	0.0018	CcSEcCtD
Midazolam—Pruritus—Temozolomide—brain cancer	0.000635	0.00179	CcSEcCtD
Midazolam—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000627	0.00563	CbGpPWpGaD
Midazolam—Gastrointestinal disorder—Etoposide—brain cancer	0.00062	0.00175	CcSEcCtD
Midazolam—Fatigue—Etoposide—brain cancer	0.000619	0.00175	CcSEcCtD
Midazolam—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000614	0.00552	CbGpPWpGaD
Midazolam—Dizziness—Carmustine—brain cancer	0.000614	0.00173	CcSEcCtD
Midazolam—Constipation—Etoposide—brain cancer	0.000614	0.00173	CcSEcCtD
Midazolam—Pain—Etoposide—brain cancer	0.000614	0.00173	CcSEcCtD
Midazolam—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000613	0.0055	CbGpPWpGaD
Midazolam—CYP3A4—endocrine gland—brain cancer	0.0006	0.00205	CbGeAlD
Midazolam—Dizziness—Temozolomide—brain cancer	0.000593	0.00167	CcSEcCtD
Midazolam—Feeling abnormal—Etoposide—brain cancer	0.000592	0.00167	CcSEcCtD
Midazolam—Vomiting—Carmustine—brain cancer	0.00059	0.00167	CcSEcCtD
Midazolam—Rash—Carmustine—brain cancer	0.000585	0.00165	CcSEcCtD
Midazolam—Dermatitis—Carmustine—brain cancer	0.000585	0.00165	CcSEcCtD
Midazolam—Headache—Carmustine—brain cancer	0.000582	0.00164	CcSEcCtD
Midazolam—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000581	0.00522	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—HES5—brain cancer	0.000576	0.00517	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000573	0.00514	CbGpPWpGaD
Midazolam—Vomiting—Temozolomide—brain cancer	0.000571	0.00161	CcSEcCtD
Midazolam—Urticaria—Etoposide—brain cancer	0.00057	0.00161	CcSEcCtD
Midazolam—CYP2B6—brain—brain cancer	0.000568	0.00194	CbGeAlD
Midazolam—Rash—Temozolomide—brain cancer	0.000566	0.0016	CcSEcCtD
Midazolam—Dermatitis—Temozolomide—brain cancer	0.000565	0.00159	CcSEcCtD
Midazolam—Headache—Temozolomide—brain cancer	0.000562	0.00159	CcSEcCtD
Midazolam—ABCB1—gonad—brain cancer	0.000562	0.00192	CbGeAlD
Midazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000554	0.00497	CbGpPWpGaD
Midazolam—Nausea—Carmustine—brain cancer	0.000552	0.00156	CcSEcCtD
Midazolam—ABCB1—pituitary gland—brain cancer	0.000548	0.00187	CbGeAlD
Midazolam—GABRR1—Ion channel transport—TRPC6—brain cancer	0.000542	0.00487	CbGpPWpGaD
Midazolam—CYP3A4—central nervous system—brain cancer	0.00054	0.00185	CbGeAlD
Midazolam—CYP2E1—brain—brain cancer	0.000533	0.00182	CbGeAlD
Midazolam—Nausea—Temozolomide—brain cancer	0.000533	0.0015	CcSEcCtD
Midazolam—Hypersensitivity—Etoposide—brain cancer	0.000529	0.00149	CcSEcCtD
Midazolam—ABCB1—medulla oblongata—brain cancer	0.000529	0.00181	CbGeAlD
Midazolam—GABRQ—Ion channel transport—TRPC6—brain cancer	0.000517	0.00464	CbGpPWpGaD
Midazolam—GABRR2—Ion channel transport—TRPC6—brain cancer	0.000517	0.00464	CbGpPWpGaD
Midazolam—Asthenia—Etoposide—brain cancer	0.000515	0.00145	CcSEcCtD
Midazolam—Pruritus—Etoposide—brain cancer	0.000508	0.00143	CcSEcCtD
Midazolam—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.0005	0.00449	CbGpPWpGaD
Midazolam—ABCB1—midbrain—brain cancer	0.000483	0.00165	CbGeAlD
Midazolam—Dizziness—Etoposide—brain cancer	0.000475	0.00134	CcSEcCtD
Midazolam—ABCB1—spinal cord—brain cancer	0.000471	0.00161	CbGeAlD
Midazolam—Vomiting—Etoposide—brain cancer	0.000457	0.00129	CcSEcCtD
Midazolam—Rash—Etoposide—brain cancer	0.000453	0.00128	CcSEcCtD
Midazolam—Dermatitis—Etoposide—brain cancer	0.000452	0.00128	CcSEcCtD
Midazolam—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000451	0.00405	CbGpPWpGaD
Midazolam—Headache—Etoposide—brain cancer	0.00045	0.00127	CcSEcCtD
Midazolam—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000444	0.00399	CbGpPWpGaD
Midazolam—Nausea—Etoposide—brain cancer	0.000427	0.0012	CcSEcCtD
Midazolam—GABRG3—Ion channel transport—TRPC6—brain cancer	0.000426	0.00382	CbGpPWpGaD
Midazolam—ABCB1—endocrine gland—brain cancer	0.000424	0.00145	CbGeAlD
Midazolam—GABRB1—Ion channel transport—TRPC6—brain cancer	0.000419	0.00377	CbGpPWpGaD
Midazolam—ABCB1—head—brain cancer	0.000419	0.00143	CbGeAlD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000419	0.00376	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000408	0.00367	CbGpPWpGaD
Midazolam—GABRA6—Ion channel transport—TRPC6—brain cancer	0.000397	0.00356	CbGpPWpGaD
Midazolam—GABRA4—Ion channel transport—TRPC6—brain cancer	0.000392	0.00352	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—S100A10—brain cancer	0.00039	0.0035	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—S100A10—brain cancer	0.00039	0.0035	CbGpPWpGaD
Midazolam—ABCB1—central nervous system—brain cancer	0.000382	0.00131	CbGeAlD
Midazolam—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000382	0.00343	CbGpPWpGaD
Midazolam—ABCB1—cerebellum—brain cancer	0.000374	0.00128	CbGeAlD
Midazolam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000368	0.0033	CbGpPWpGaD
Midazolam—GABRB2—Ion channel transport—TRPC6—brain cancer	0.000358	0.00322	CbGpPWpGaD
Midazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000352	0.00316	CbGpPWpGaD
Midazolam—GABRA5—Ion channel transport—TRPC6—brain cancer	0.000348	0.00313	CbGpPWpGaD
Midazolam—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000347	0.00312	CbGpPWpGaD
Midazolam—GABRA3—Ion channel transport—TRPC6—brain cancer	0.000342	0.00307	CbGpPWpGaD
Midazolam—GABRA2—Ion channel transport—TRPC6—brain cancer	0.000336	0.00302	CbGpPWpGaD
Midazolam—GABRB3—Ion channel transport—TRPC6—brain cancer	0.000334	0.003	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000333	0.00299	CbGpPWpGaD
Midazolam—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000329	0.00295	CbGpPWpGaD
Midazolam—GABRG2—Ion channel transport—TRPC6—brain cancer	0.000328	0.00294	CbGpPWpGaD
Midazolam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000328	0.00294	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000326	0.00293	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000326	0.00292	CbGpPWpGaD
Midazolam—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000322	0.00289	CbGpPWpGaD
Midazolam—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000321	0.00288	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000321	0.00288	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000316	0.00284	CbGpPWpGaD
Midazolam—ABCB1—brain—brain cancer	0.000304	0.00104	CbGeAlD
Midazolam—GABRA6—Transmembrane transport of small molecules—S100A10—brain cancer	0.000299	0.00269	CbGpPWpGaD
Midazolam—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000299	0.00268	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—S100A10—brain cancer	0.000295	0.00265	CbGpPWpGaD
Midazolam—GABRA1—Ion channel transport—TRPC6—brain cancer	0.000286	0.00257	CbGpPWpGaD
Midazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000285	0.00256	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—S100A10—brain cancer	0.00027	0.00242	CbGpPWpGaD
Midazolam—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000265	0.00238	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—S100A10—brain cancer	0.000262	0.00236	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000258	0.00231	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—CYP2C9—brain cancer	0.000255	0.00229	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000253	0.00227	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000252	0.00226	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000247	0.00222	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000245	0.0022	CbGpPWpGaD
Midazolam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000229	0.00206	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—SPP1—brain cancer	0.000218	0.00196	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—BSG—brain cancer	0.000217	0.00195	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000216	0.00194	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—IRS2—brain cancer	0.000198	0.00177	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—HES1—brain cancer	0.00019	0.00171	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000189	0.00169	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—IDH1—brain cancer	0.000186	0.00167	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000185	0.00166	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00018	0.00162	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00018	0.00162	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—APC—brain cancer	0.000174	0.00157	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CYP2C9—brain cancer	0.00016	0.00143	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000157	0.00141	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000152	0.00136	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000151	0.00136	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000149	0.00134	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000148	0.00133	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—ENO2—brain cancer	0.000147	0.00132	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000146	0.00131	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000138	0.00124	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000136	0.00122	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—RELA—brain cancer	0.000136	0.00122	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—BSG—brain cancer	0.000136	0.00122	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000131	0.00117	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000125	0.00112	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000124	0.00111	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000121	0.00109	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000119	0.00107	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—CTNNB1—brain cancer	0.000119	0.00106	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000117	0.00105	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—IDH1—brain cancer	0.000117	0.00105	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000116	0.00104	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000114	0.00102	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000108	0.000972	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000105	0.000938	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—STAT3—brain cancer	0.000103	0.000928	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—TRPC6—brain cancer	9.97e-05	0.000895	CbGpPWpGaD
Midazolam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	9.79e-05	0.000879	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	9.54e-05	0.000857	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ENO2—brain cancer	9.22e-05	0.000828	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	8.58e-05	0.000771	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL2—brain cancer	8.54e-05	0.000767	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—TRPC6—brain cancer	8.53e-05	0.000766	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	8.42e-05	0.000756	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—brain cancer	8.4e-05	0.000754	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	8.38e-05	0.000753	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	8.31e-05	0.000746	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	7.73e-05	0.000694	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP2C9—brain cancer	7.7e-05	0.000692	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	7.36e-05	0.000661	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—VEGFA—brain cancer	7.26e-05	0.000652	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP2C9—brain cancer	7.17e-05	0.000644	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3CG—brain cancer	6.76e-05	0.000607	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—BSG—brain cancer	6.55e-05	0.000588	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	6.37e-05	0.000572	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—BSG—brain cancer	6.1e-05	0.000547	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	5.99e-05	0.000538	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP2C9—brain cancer	5.7e-05	0.000512	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—IDH1—brain cancer	5.63e-05	0.000506	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP2C9—brain cancer	5.58e-05	0.000501	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP2C9—brain cancer	5.57e-05	0.0005	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—IDH1—brain cancer	5.24e-05	0.000471	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	5e-05	0.000449	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—BSG—brain cancer	4.84e-05	0.000435	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—BSG—brain cancer	4.75e-05	0.000426	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—BSG—brain cancer	4.74e-05	0.000425	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	4.65e-05	0.000418	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ENO2—brain cancer	4.45e-05	0.0004	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CG—brain cancer	4.23e-05	0.00038	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP2C9—brain cancer	4.2e-05	0.000377	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—IDH1—brain cancer	4.17e-05	0.000374	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ENO2—brain cancer	4.14e-05	0.000372	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.11e-05	0.000369	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—IDH1—brain cancer	4.08e-05	0.000366	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—IDH1—brain cancer	4.07e-05	0.000366	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.07e-05	0.000365	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.58e-05	0.000322	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—BSG—brain cancer	3.57e-05	0.000321	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.3e-05	0.000296	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ENO2—brain cancer	3.29e-05	0.000296	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ENO2—brain cancer	3.23e-05	0.00029	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.22e-05	0.00029	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ENO2—brain cancer	3.22e-05	0.000289	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—IDH1—brain cancer	3.07e-05	0.000276	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.71e-05	0.000243	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP2C9—brain cancer	2.59e-05	0.000232	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ENO2—brain cancer	2.43e-05	0.000218	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—BSG—brain cancer	2.2e-05	0.000198	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CG—brain cancer	2.04e-05	0.000183	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CG—brain cancer	1.9e-05	0.000171	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—IDH1—brain cancer	1.89e-05	0.00017	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CG—brain cancer	1.51e-05	0.000136	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ENO2—brain cancer	1.5e-05	0.000134	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CG—brain cancer	1.48e-05	0.000133	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CG—brain cancer	1.48e-05	0.000133	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CG—brain cancer	1.11e-05	0.0001	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CG—brain cancer	6.87e-06	6.16e-05	CbGpPWpGaD
